Medical Marketing and Media - One to One names life sciences head
DIGITAL MARKETING firm One to One Interactive has named Gayatri Bhalla group director of its life sciences division.
In her new role, Bhalla will be responsible for the strategic direction of the life science practice, which oversees interactive accounts for GlaxoSmithKline’s Avandia, Advair, Wellbutrin, Lamictal (bipolar and epilepsy) and Valtrex, as well as Roche’s transplantation franchise, including Cellcept and Zenapax.
“A shift is taking place in the consumer health space, as more and more people are actively engaging in the use of interactive mediums to validate trusted vendors and to make well-informed purchasing decisions,” Bhalla said. “I am pleased to offer my knowledge and insight.”
Related Results
GSK ‘vindicated’ by drugs case victory
Paperless medicine: for years, doctors have recognized the power of informati…
Label change.(GlaxoSmithKline PLC’s Lamictal)(Brief Article)
The art of Sheila Mann.(care and treatment)(achievements)
New Hope For Seizures
Bhalla has been in the life sciences area since 1997, working with GlaxoSmithKline, Pfizer and Millennium Pharmaceuticals.-SM
Copyright Haymarket Media, Inc. Jun 2006
Provided by ProQuest Information and Learning Company. All rights Reserved
